Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice
Sign Up to like & getrecommendations! Published in 2017 at "International Journal of Hematology"
DOI: 10.1007/s12185-017-2275-4
Abstract: Eltrombopag is safe and effective in primary chronic ITP. However, lack of clinical trials avoids a clear demonstration of its utility in newly diagnosed and persistent ITP. Our aim here is to report Spanish results… read more here.
Keywords: newly diagnosed; diagnosed itp; chronic itp; efficacy ... See more keywords